Sun Pharma trips 6% on USFDA import alert for Karkhadi unit

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Shares of Sun Pharmaceutical Industries fell more than 6 percent intraday Thursday on getting USFDA import alert for its Karkhadi unit in Gujarat.

US Food and Drug Administration has given import alert for all products from this unit. It is the first import alert for Sun Pharma.

However, the drug maker said US FDA import ban on Karkhadi Unit would have negligible impact, reports CNBC-TV18 quoting Reuters.

At 09:54 hours IST, the stock fell 4.5 percent to Rs 576.75 amid high volumes on the BSE.

Meanwhile, its subsidiary Caraco on Wednesday received approval from US Food and Drug Administration for Risperidone oral tablet that is used for the treatment of schizophrenia (a mental disorder).

However, the healthcare major on Monday had voluntarily recalled 2,528 bottles of its generic version of diabetes drug Glumetza from US-based Santarus Inc after it received a customer complaint.

Posted by Sunil Shankar Matkar